The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Clinical Trials, Phase IV
Hierarchy: | ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV 6 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ |
Broader terms: | ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ Clinical Trials, Phase IV ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase IV |
Annotation: | for U.S. & foreign studies; IM for articles & books about phase IV clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE IV; DF: CLIN TRIALS PHASE IV
X |
History note: | Clinical Trials (1980-1992)X |
historyNote*: | 93; DRUG EVALUATION, FDA PHASE IV was see CLINICAL TRIALS 1981-92; EVALUATION STUDIES, FDA PHASE IV was see CLINICAL TRIALS 1982-92
X |
onlineNote*: | use CLINICAL TRIALS to search DRUG EVALUATION, FDA PHASE IV 1980-92 & EVALUATION STUDIES, FDA PHASE IV 1981-92
X |
publicMeSHNote*: | 93; DRUG EVALUATION, FDA PHASE IV was see CLINICAL TRIALS 1981-92; EVALUATION STUDIES, FDA PHASE IV was see CLINICAL TRIALS 1982-92
X |
Scope note: | Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.
X |
activeMeSHYear*: | |
dateCreated*: | 1992-05-13X |
dateEstablished*: | 1993-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | ssbX |
recordOriginator*: | TPWX |
Related term: | |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Kliiniset kokeet, vaihe IV (fi) XKliininen koe, vaihe IV (fi, replaced) Vaiheen III kliininen koe (fi, replaced) Vaiheen III kliiniset kokeet (fi, replaced) Kliniska prövningar, fas IV (sv) Phase IV Clinical Trials (en, replaced) Phase 4 Clinical Trials (en, replaced) Drug Evaluation, FDA Phase 4 (en, replaced) Drug Evaluation, FDA Phase IV (en, replaced) Evaluation Studies, FDA Phase 4 (en, replaced) Clinical Trials, Phase 4 (en, replaced) |
Share: |
Loading results...